What question did this study set out to answer?

This research aims to identify and characterize molecular subtypes of urothelial carcinoma (UC) to enhance precision therapy.

March 12, 2026

Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy.

Puntos clave

This research aims to identify and characterize molecular subtypes of urothelial carcinoma (UC) to enhance precision therapy.
Developed three UC clusters applicable for muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer (NMIBC)
Validated clusters using transcriptomic and proteomic datasets
Assigned publicly available UC cell lines to the clusters to create in vitro models
Clusters exhibit distinct molecular and biological signatures
Each cluster has unique prognostic and therapeutic characteristics

Resumen

We developed three UC clusters, applicable for MIBC and NMIBC, which were validated using transcriptomic- and proteomic datasets. Publically available UC cell lines were assigned to the clusters, to have in vitro models representing each cluster. The clusters differ in molecular and biological signatures, with distinct prognostic and therapeutic characteristics.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Creij et al. (Sun,) studied this question.

synapsesocial.com/papers/69b25aea96eeacc4fcec91cf https://doi.org/https://doi.org/10.1002/ctm2.70638

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Preguntar a la IA

Me gusta

Guardar